Phillip A. Sharp Innovation in Collaboration Award: Resistance to PARP Inhibitor Plus Anti-PD1 Therapy Driven by ER Stress and Bioactive Lipids in Ovarian Cancer - Stand Up To Cancer

Blog

Posted October 9, 2019

Phillip A. Sharp Innovation in Collaboration Award: Resistance to PARP Inhibitor Plus Anti-PD1 Therapy Driven by ER Stress and Bioactive Lipids in Ovarian Cancer

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.